Amerikanische Gesellschaft für Hirudotherapie

Use of expanded reverse sural artery flap in lower extremity reconstruction

Research article published in Journal of foot and ankle surgery (2011)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyKlinische StudienKose AA et al. · Journal of foot and ankle surgery, 2011

Abstract

Coverage of defects of the distal third portion of the leg and foot remains a challenge for surgeons. The difficulty results from the limited mobility and availability of the overlying skin, the weight-bearing requirements, and the relatively poor circulation of the skin. From January 2008 to December 2009, 10 patients had defects of the foot and ankle covered using the 2-stage expanded reverse sural flap. Of these 10 patients, 6 had at least 1 risk factor for compromised wound healing, such as diabetes mellitus, peripheral arterial disease, venous insufficiency, tobacco smoking, or age older than 40 years. Flap necrosis was observed in only 1 patient (10%). Venous congestion was noted in 2 patients (20%) by the third postoperative day, 1 of whom responded to postural elevation of the extremity and 1 to medicinal leech therapy. Although it is a 2-stage procedure that requires wound dressing during the expansion, we strongly suggest the use of the expanded reverse sural flap for defects too large to be primarily closed, especially in patients older than 40 years with risk factors such as diabetes mellitus, peripheral arterial disease, or venous insufficiency.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAdolescentAdultAgedArteriesChildFemaleFollow-Up StudiesFoot InjuriesGraft SurvivalHumansLeg InjuriesMale

Zusammenfassung

Use of expanded reverse sural artery flap in lower extremity reconstruction.

Warum dies für die Hirudotherapie relevant ist

The article reports a two-stage expanded reverse sural flap technique for covering distal leg and foot defects in 10 patients, six of whom had at least one risk factor for compromised wound healing. Flap necrosis occurred in one patient (10%), and venous congestion was noted in two patients (20%) by the third postoperative day; one responded to postural elevation and one responded to medicinal leech therapy. This is relevant to ASH's domain because the abstract explicitly documents medicinal leech therapy as a clinical intervention used for venous congestion in a reconstructive flap. The caveat is that leech therapy is mentioned only for one patient, without species, protocol, duration, or outcome detail beyond 'responded to'; the study's main focus is flap technique rather than hirudotherapy.

Zitation

Use of expanded reverse sural artery flap in lower extremity reconstruction

Kose AA et al. · Journal of foot and ankle surgery, 2011

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.